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Abstract 
In an attempt to find a relationship between pulmonary 
infection and pulmonary function in cystic fibrosis (CF) patients, 
microbiology data and pulmonary function test (PFT) data for clinic 
patients' visits were obtained from the University of Minnesota 
Relational Database. The two files were merged, totaling 12,193 
cases, and then analyzed using a quick cluster subroutine of SPSSX 
on the University of Illinois IBM Mainframe System. QUICK CLUSTER 
analysis showed a relationship between the virulence of the 
microorganisms, the amount of growth of the microorganisms, and 
the pulmonary function test scores of CF patients 
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Background 
Cystic fibrosis (CF) is an autosomal recessive disease. The 
loss of a single specific trinucleotide codon accounts for about 70% 
of CF cases. The gene involved codes for an ion channel regulator 
protein called the Cystic Fibrosis Transmembrane Regulator protein 
(CFTR). The production of defective CFTR proteins results in 
abnormal regulation of chloride ion channels which leads to 
abnormally thick mucus secretions (1). Viscid mucus secretions 
obstruct the lungs and provide a suitable environment for infection 
by microorganisms. Infection, in turn, causes mucus hypersecretion. 
Recurrent pulmonary infection results in destruction of lung 
parenchyma (2). 
The original aim of this study was to determine if there were 
correlations between clinical microbial data and home monitoring 
data. Home monitoring allows the physician to follow the patient's 
health status while the patient is at home instead of in the hospital 
or clinic (3). Sometimes, changes in the CF patient's health occur 
slowly and may go unrecognized by the patient or parent/support 
team resulting in an increased morbidity and/or mortality (4). It 
was hoped that the correlations would provide earlier detection of 
negative trends and confirm stability or improving health between 
clinic visits. With earlier detection of deteriorating health status, 
treatment becomes more effective. This is especially important 
today in light of recent developments in cystic fibrosis research, 
and the possibility of gene therapy in the near future. 
Ninety percent of all CF deaths are due to respiratory failure 
(5). The three bacterial organisms that chronically colonize the 
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airways of cystic fibrosis patients are Staphylococcus aureus, 
Hemophilus influenzae, and Pseudomonas aeruginosa (6). Other 
microorganisms, for example, fungi such as Aspergillus and Candida 
albicans, also are common in CF sputum (7). Clinical symptoms of 
infection include increasingly productive cough with yellow or green 
sputum, wheeze, weight loss, and fever (5). These symptoms were 
included in home monitoring. 
For the purposes of the original proposal, pulmonary function 
tests (PFTs) would have been used as a measure of wellness. If the 
research had shown a relationship between the microbial data and 
the PFT data and the same relationship between the home data and 
the PFT data, then, perhaps, the home data could have been used as a 
predictor of patient status between clinic visits. Unfortunately, the 
time remaining to complete the research project was not sufficient 
to be able to combine the computer files containing the microbe 
data, the home monitoring data, and the PFT data. Therefore, it was 
decided to investigate the relationships between the microbiology 
and the patient's health status, as indicated by PFT scores, by using 
QUICK CLUSTER analysis. 
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Methods 
One hundred and seventy three CF patients receiving treatment 
from the Cystic Fibrosis Center at the University of Minnesota 
volunteered to record daily symptoms and measurements in a home 
health diary. These data were sent to the CF Center weekly and were 
entered into the (10M/IBM) relational database system. The patient's 
status according to the attending physician and other data, such as 
PFT scores and microorganisms grown in culture, were also entered 
for each clinic visit. 
A visit to the University of Minnesota in October 1990 led to a 
meeting with several of the University Staff, Dr. Warren Warwick, 
Dr. Stan Finkelstein and Cathy Wielinski, and a discussion concerning 
the data that would be retrieved. In January 1991, the requested 
data from the entire time span of the relational database (1982­
1986) were received. These included microbiology and pulmonary 
function information from each clinic visit, and home data from two 
weeks before and two weeks after each clinic visit. The home data 
were collected for this time span because CF patients were more apt 
to complete the home diaries at these times. In addition, the home 
data from this time period are more likely to indicate a change in 
patient health status because treatment is usually altered by the 
physician at the clinic visit. 
SPSSX was used for statistical analysis of the data. The 
format of the microbiology data was altered in order to be 
compatible with SPSSX requirements. That is, it had to be changed 
such that each variable had the same number of characters. SPSSX 
on the University of Illinois IBM Mainframe System was used to 
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analyze the data because Illinois Wesleyan's PC version could not 
handle the large amount of data collected. 
The microbiology file, MICRO OAT A, contained the following 
data. 
1. microbe name 
2. microbe strain 
3.	 source of culture
 
a) tr = trachea
 
b) sp = sputum
 
c) th = throat
 
d) ur = urine
 
e) bl = blood
 
f) br = bronchial washing
 
g) ot = other
 
4.	 microbe growth
 
a) I = light
 
b) m = moderate
 
c) h = heavy
 
Because the SPSSX procedures used require all variables to be 
numeric, the growth of the microbes, the source of culture , and the 
microorganisms themselves had to be assigned numeric values. In 
addition to being assigned a numeric value, the microorganisms were 
ranked according to their degree of virulence by Dr. Warwick (11). 
The microbes ranged from 1 being the mildest to 8 being the most 
severe with regard to degree of resulting pulmonary infection. 
1.	 growth
 
a) light = 1
 
b) moderate = 2
 
c) heavy = 3
 
2.	 source
 
a) tr = 1
 
b) sp = 2
 
c) th = 3
 
d) ur = 4
 
e) bl = 5
 
-6 
f) br = 6
 
g) ot = 7
 
3.	 microbes (name/numerical value/virulence rankage) 
Acremonium species / 1 /1 
Acinetobacter calcoaceticus v. Iwoffii / 2 /1 
Acinetobacter calcoaceticus v. anitratus / 3 / 1 
Acinetobacter species / 4 / 1 
Acinetobacter calcoaceticus / 5 / 1 
Achromobacter xylosoxidans / 6 / 1 
Achromobacter species / 7 / 1 
Aeromonas hydrophilia / 8 / 1 
Agrobacterium radiobacter / 9 / 1 
Alternaria species / 10 / 1 
Alcaligenes species / 11 / 1 
Alcaligenes odorans / 12 / 1 
Alcaligenes denitrificans / 13 / 1 
Aspergillus fumigatus / 14 / 1 
Aspergillus versicolor / 15 / 1 
Aspergillus terreus / 16 / 1 
Aspergillus flavus / 17 / 1 
Aspergillus clavatus / 18 / 1 
Aspergillus niger / 19 / 1 
Bacillus species (gram -) (non-fermenter) / 20 / 1 
Branhamella Catarrhalis / 21 / 1 
Bacillus species-not anthracis / 22 / 1 
Bacillus species (gram -) / 23 / 1 
Bacillus species / 24 / 1 
Candida parapsilosis / 25 / 1 
Candida albicans / 26 / 1 
Candida tropicalis / 27 / 1 
Candida lusitaniae / 28 / 1 
Candida rugosa / 29 / 1 
Cladosporium species / 30 / 1 
Citrobacter amalonaticus / 31 / 1 
Citrobacter freundii / 32 / 1 
Citrobacter diversus / 33 / 1 
CDC Group VE-2 (non-fermenter) / 34 / 1 
Enterobacter taylorae / 35 / 1 
Enterobacter agglomerans / 36 / 1 
Enterobacter aurogenes / 39 / 1 
Enterobacter sakazakii / 40 / 1 
Fungus (filamentous) / 41 / 1 
Fusarium species / 42 / 1 
•
 
7
 
Flavobacterium species / 43 / 1
 
Petriellidium boydii /71 / 1
 
Staphylococcus aureus / 91 / 3
 
Hafnia alvei / 45 / 1
 
Klebsiella oxytoca / 46 / 1
 
Klebsiella pneumonia / 47 / 1
 
Klebsiella ozaenae / 48 / 1
 
Moraxella phenylpyruvica / 49 / 1
 
Mucor species / 50 / 1
 
Moraxella species / 51 / 1
 
Morganella morganii / 52 / 1
 
Orzihabitans (pseudo) / 53 / 1
 
Penicillium species / 72 / 1
 
Providencia rettgeri / 73 / 1
 
Providencia stuartii / 74 / 1
 
Proteus vulgaris / 75 / 1
 
Proteus mirabilis / 76 / 1
 
Pasteurella multocida / 77 / 1
 
Rod (Lactose-) (non-fermenter) / 78 / 1
 
Serratia marcescens / 79 / 1
 
Serratia liquefacians / 80 / 1
 
Saprophyte non-sporulating / 81 / 1
 
Scapulariopsis species / 82 / 1
 
Streptococcus beta (group A) / 83 / 1
 
Streptococcus beta (non-group A) / 84 / 1
 
Streptococcus species / 85 / 1
 
Streptococcus pneumonia (Diplococcus) / 86 / 1
 
Streptococcus beta hemolytic (group B) / 87 / 1
 
Streptococcus beta hemolytic (group C) / 88 / 1
 
Streptococcus beta hemolytic (group G) / 89 / 1
 
Streptocuccus beta hemolytic / 90 / 1
 
Saccharomyces cerevisiae / 94 / 1
 
Trichosporon beigelii / 95 / 1
 
Trichosporon species / 96 / 1
 
Trichoderma species / 97 / 1
 
Unspecified Lactose non-fermenter / 98 / 1
 
Unspecified Lactose fermenter / 99 / 1
 
Escherichia coli / 37 / 2
 
Escherichia coli (mucoid) / 38 / 2
 
Staphylococcus species (Coag-) / 92 / 3
 
Staphylococcus epidermidis / 93 / 3
 
Hemophilus influenzae / 44 / 4
 
Pseudomonas species / 54 / 5
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Pseudomonas species (mucoid) / 55 / 5
 
Pseudomonas species (brown pig) / 56 / 5
 
Pseudomonas species (Huorescen) / 57 / 5
 
Pseudomonas thomasii /61 / 5
 
Pseudomonas stutzeri / 62 / 5
 
Pseudomonas alcaligenes / 63 / 5
 
Pseudomonas putida /64/ 5
 
Pseudomonas pickettii / 65 / 5
 
Pseudomonas f1uorescense / 66 / 5
 
Pseudomonas f1uorescense (mucoid) / 67 / 5
 
Pseudomonas paucimoblis / 68 / 5
 
Pseudomonas luteola / 69 / 5
 
Pseudomonas medoncina / 70 / 5
 
Pseudomonas aeruginosa / 59 / 6
 
Pseudomonas aeruginosa (mucoid) / 60 / 7
 
Pseudomonas cepacia / 58 / 8
 
The pulmonary function file, PFT OUT B, contained the following data. 
FEV = (FEF1/FVC) 
where FEF1 = forced expiratory flow rate in 1 sec. 
FVC = forced vital capacity [the quantity of 
air expired forcefully after inspiring 
maximally (9)] 
FEV = forced expiratory volume (FEF1 as 
percent of total FVC) 
FVC = (FVC/PFVC) 
where FVC = percent forced vital capacity of 
predicted 
FEF1 = (FEF1/PFEF1) 
where FEF1 = percent forced expiratory flow in 1
 
sec. of predicted
 
MICRO DAT A and PFT OUT B were sorted by patient 
identification number and clinical date and were merged into one 
file, CLINIC OUT B. There was a total of 12,193 cases. Because 
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there was such a large amount of data, QUICK CLUSTER analysis was 
used to find relationships between pulmonary infection and 
pulmonary function. First, three clusters for each of the variables 
were determined. Next, the center, a vector, for each of the three 
clusters for each variable was found. Finally, the variables were 
regrouped according to the cluster centers. 
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Results and Discussion 
Appendices A, B, C, and D show the results of QUICK CLUSTER 
analysis. Initial Cluster Centers are the original three cluster groups 
for each variable. Classification Cluster Centers are the centers of the 
three cluster groups for each variable. Final Cluster Centers are the 
final three cluster groups for each variable after the variables are 
regrouped according to the cluster centers. IMPORTM is the average 
value of the codes for virulence for each cluster. CODES is the average 
value of the codes for the culture source for each cluster. CODEG is the 
average value of the codes for the growth of the microorganisms for 
each cluster. The average values for FEV, FVC, and FEV1 for each cluster 
are also shown. 
QUICK CLUSTER analysis indicated relationships between 
pulmonary infection and pulmonary function. Appendix A shows the 
results when IMPORTM, CODES, STRAIN, CODEG, FEV, FVC, and FEV1 were 
clustered together. As the severity of the microorganisms increased, 
there was a decrease in pulmonary function indicated by decreasing PFT 
values. In addition, as the growth of the microbes became heavier, the 
PFT values decreased. Table 1 is a summary of Appendix A. 
Table 1 Relationship Between Virulence (IMPORTM), Growth (CODEG), & 
Pulmonary Function (FEV, FVC, FEV1) 
Cluster IMPORTM cxn:G FEV FVC FEV1 
3 2.7054 1.2900 82.4747 111.3475 100.3203 
1 3.5916 1.7556 65.6977 89.1721 65.4064 
2 4.0883 2.0497 50.3027 52.0539 29.4637 
[Cluster 3 = mild pulmonary involvement]
 
[Cluster 1 = moderate pulmonary involvemen]
 
[Cluster 2 = severe pulmonary involvement]
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CODES for each cluster in Appendix A has a value close to 2 because most 
cultures were obtained from sputum. This is because pulmonary infection in 
cystic 'fibrosis patients does not appear to spread systemically (2). 
Appendix B shows the results when IMPORTM, CODEG, FEV, FVC, and FEV1 
were clustered together. A similar relationship as in Appendix A existed 
between the microbes and the PFTs and between the growth of the microbes and 
the PFTs. Table 2 is a summary of Appendix B. 
Table 2 Relationship Between Virulence (IMPORTM), Growth (CODEG), &
 
Pulmonary Function (FEV, FVC, FEV1)
 
Cluster IMPORTM CXIEG rut FVC EEV1 
1 2.3766 1.7042 83.2243 114.4795 104.0333 
3 2.9295 2.1171 69.5367 91.0235 70.1553 
2 3.3933 2.6035 45.5300 52.8268 26.7922 
[Cluster 1 = mild pulmonary involvement]
 
[Cluster 3 = moderate pulmonary involvement]
 
[Cluster 2 = severe pulmonary involvement]
 
Appendix C shows the results when IMPORTM, FEV, FVC, and FEV1 were 
clustered together. Note that increased microbe severity does correspond to 
decreased PFT values. Table 3 is a summary of Appendix C. 
Table 3 Relationship Between Virulence (IMPORTM) & Pulmonary Function 
(FEV,FVC, FEV1) 
Cluster IMPORTM FEV FVC FEV1
 
2 2.4158 82.7902 113.4465 102.6389
 
3 2.9335 68.9998 90.1445 68.8836
 
1 3.4043 45.4341 53.0171 26.8405
 
[Cluster 2 = mild pulmonary involvement] 
[Cluster 3 = moderate pulmonary involvement] 
[Cluster 1 = severe pulmonary involvement] 
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Although, the differences in severity do not seem to be as large as one 
might expect, there are number of reasons why the differences are slight. 
First, though severity was ranked from 1 through 8, the actual number of 
mild cases was much larger than the number of severe cases. This is 
evident in Appendix E which shows the frequency distribution of the 
microorganisms after they were ranked according to virulence. Note too 
that Appendix E shows that the microbe ranked with a severity of 4, 
Hemophilus influenzae, has no cases because of a misspelling in the coding 
section of the program. The results were affected since this 
microorganism is very common in CF sputum. In addition, increasing the 
number of cluster groups might lead to fewer misclassifications of the 
variables and thus, improve results. Lastly, there is the possibility that 
one cannot find a strong relationship between PFT values and microbe 
virulence alone. 
A question may be raised as to whether or not the ranking in 
virulence of the microorganisms might be based on past pulmonary 
function test results, thus influencing the results of QUICK CLUSTER 
analysis. However, if this were the case, one would expect a much larger 
difference between the clusters indicating the relationship between 
IMPORTM and PFT values. Instead, the rankings were made primarily on 
the ability of the microorganism to invade the body, resist treatment, and 
produce varying degrees of harmful effects on the host. 
Staphylococcus aureus is usually the first organism to cause 
pulmonary infection in cystic fibrosis patients. The bacteria injures the 
pulmonary tissue by producing toxins, such as hyaluronidase and 
necrotoxins, and by eliciting the host inflammatory response (10). 
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Furthermore, mucus hypersecretion and bronchoconstriction are 
stimulated by the presence of bacterial antigens (2). 
Staphylococcus aureus is found in patients with mild pulmonary 
disease. Hemophilus influenzae and Pseudomonas aeruginosa 
appear after the initial infection has occurred and are associated 
with moderate to severe pulmonary disease. The conversion of 
Pseudomonas to a mucoid form is a unique characteristic of cystic 
fibrosis (10). It is found in 90 percent of all CF patients because 
once infection has occurred , the bacteria are rarely eliminated (6). 
Pseudomonas aeruginosa produces a dense capsule (alginate) which 
protects the bacteria from the host's immune system and antibiotics 
(10). Mucoidy also helps the bacteria to adhere to the respiratory 
tract and seems to provide a selective advantage for colonization 
and obstruction of the small airways (5). In addition, several 
enzymes produced by this bacteria can injure the pulmonary tissue. 
Colonization by Pseudomonas cepacia is a poor prognostic sign 
because this bacteria is resistant to many common antipseudomonal 
antibiotics (7). 
PFTs are used to evaluate treatment and progression of 
pulmonary involvement (11). A decrease in FEV1 is an indicator of 
deterioration of pulmonary of function. In general, it is predicted 
that the CF patient will be alive in four years if the FEV1 is greater 
than 60% of the predicted value. If the FEV1 is less than 35% of 
predicted, however, the patient has only a 60% chance of being alive 
in the next four years (7). Figure 1, taken from Simmons Current 
Pulmonology (2), relates well with the QUICK CLUSTER results. The 
values given for FEV1 in Figure 1 are similar to the FEV1 values for 
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mild, moderate, and severe lung involvement given in Tables 1, 2, 3, 
and 4. The much lower value for severe lung involvement determined 
by the QUICK CLUSTER analysis, compared to that given in Figure 1, 
may be due to the missing Hemophilus influenzae data. 
Figure 1 "Progressive Pulmonary Function Abn 0 rmal itites in Cystic 
Fibrosis" (2) 
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FIG 8. 
Representative progress of deterioration of pulmonary function in a subject. FEY, .. forced 
expiratory volume at I second; RVrrLC = residual volumeJtotallung capacity; FEYu _7J = 
forced expiratory flow over the middle half of the total volume exhaled; MEFV .. maximal 
expiratory flow-volume curve; Pr~d. .. predicted; N .. normal. (From Taussig LM. lan­
dau LI. Marks MI: Respiratory system. in Taussig LM (ed): Cyslic Fibrosis. New York. 
Thieme~tralton Inc. 1984. pp 115-174. Reproduced by permission.) 
Appendix 0 shows the results wilen CODEG, FEV, FVC, and FEV1 
are clustered together. Note that an increase in microbe growth 
does relate to a decrease in PFT values. Table 4 is a summary of 
- Appendix D. 
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Table 4 Relationship Between Growth (CODEG) & Pulmonary Function 
(FEV, FVC, FEV1) 
Cluster CCIE3 FEV FVC FEV1 
1 1.6930 82.7923 113.4438 102.6395 
3 2.1535 68.9982 90.1464 68.8832 
2 2.6029 45.4341 53.0171 26.8405 
[Cluster 1 = mild pulmonary involvement] 
[Cluster 3 = moderate pulmonary involvement] 
[Cluster 2 = severe pulmonary involvement] 
Originally, CORRELATIONS analysis was attempted (see Appendix F). 
However, little correlation was actually found between IMPORTM and PFT 
values or between CODEG and PFT values (Table 5). Still, the correlation 
coefficients do show a negative correlation which was expected. 
Table 5 Correlation Coefficients for Virulence (IMPORTM), Growth 
(CODEG), & Pulmonary Function (FEV, FVC, FEV1) 
FEV FVC FEV1 
IMPORTM -.1880 -.1277 -.1661 
cca;G -.2853 - .1984 -.2562 
correlation coefficient 0 = no correlation]
 
correlation coefficient 1 = perfect positive correlation]
 
correlation coefficient -1 = perfect negative correlation]
 
A possible reason for these results is that the predictor variables, 
IMPORTM and CODEG, have to few categories while the predicted variables, 
FEV, FVC, FEV1, have extremely wide ranges. Thus, little correlation was 
shown. 
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Conclusion 
QUICK CLUSTER analysis of cystic fibrosis clinical microbial 
data and pulmonary function tests indicate a relationship between 
the virulence of the microorganisms and/or the amount of growth of 
the microorganisms and pulmonary function. Perhaps these results, 
in conjunction with the home monitoring data, could be used to 
predict when more intensive treatment should be used to prevent 
further deterioration of pulmonary function. The cluster analyses 
are only exploratory; further analysis, including program error 
corrections, is required for more definite conclusions. 
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23-Apr-91 SPSS-x RELEASE 3.1 FOR IBM VM/CMS Page 11 
09: 18: 13 COfolPUTING SERVICES OFFICE-UIUC IBM 3081 VM/SP CMS 
* * * * * * * * * * * * * * * * * * * * * * * * * QUI C K C L U S T E R * * * * * * * * * * * * * * * * * * * * * * * * * 
Initial Cluster Centers. 
Cluster IMPORTM CODES STRAIN COOEG FEY FVC FEYl 
1 7.0000 2.0000 .0000 3.0000 34.1500 115.1700 45.9900
 
2 1.0000 2.0000 .0000 3.0000 97.1900 28.0000 29.7800
 
3 1.0000 3.0000 .0000 2.0000 95.6200 148.8700 145.8200
 
Classification Cluster Centers. 
Cluster IMPORTM CODES STRAIN COOEG FEY FVC FEYl 
1 5.2001 2.1176 .1094 2.3684 47.0644 94.7717 51.0831
 
2 4.0180 2.1010 .1324 2.5074 65.6872 40.8089 27.7645
 
3 2.3944 2.5666 .0922 1.6892 83.7750 127.9735 118.8138
 
> 
'"d 
'"dFinal Cluster Centers. 
roCluster IMPORTM CODES STRAIN CODEG FEY FVC FEY1 ::3 
a. 
1 3.5916 2.4754 .1173 1.7556 65.6977 89.1721 65.4064 .... 
,.2 4.0883 2.1943 .1954 2.0497 50.3027 52.0539 29.4637 y
3 2.7054 2.8085 •0712 1.2900 82.4747 111.3475 100.3203 > 
Number or Cases in each Cluster. 
Cluster unweighted cases weighted cases 
1 1927.0 1927.0 
2 906.0 906.0 
3 1979.0 1979.0 
r1isslng 7381
 
Total 4812.0 4812.0
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -- - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
23-Apr-91 SPSS-x RELEASE 3.1 FOR IBM VM/CMS	 Page 13 
09: 18: 41 COMPUTING SERVICES OFFICE-UIUC IBM 3081 VM/SP CMS 
* * * * * * * * * * * * * * * * * * * * * * * * * QUI C K C L U S T E R * * * * * * * * * * * * * * * * * * * * * * * * * 
Initial Cluster Centers. 
Cluster IMPORTI-l CODEG FEV FVC FEVl 
1 1.0000 4.0000 84.9100 172.6800 150.4500
 
2 1.0000 4.0000 64.1000 14.3000 10.0900
 
3 1.0000 4.0000 35.3500 129.6900 48.5900
 
Classirication Cluster Centers. 
Cluster IfoIPORTM CODEG FEV FVC FEVl 
1 2.4272 2.1505 80.9432 130.5390 117.6164
 
2 3.8327 2.5619 41.1350 44.7907 18.8694
 
3 3.4948 2.5862 56.7131 98.4568 61.2192
 
>Final Cluster Centers.	 "'0 
'0 
IIICluster IMPORTM CODEG FEV FVC FEVl 
Q,=1 2.3766 1.7042 83.2243 114.4795 104.0333	 ~ 
...2 3.3933 2.6035 45.5300 52.8268 26.7922 
" 3 2.9295 2.1171 69.5367 91.0235 70.1553 CX' 
Number or Cases in each Cluster. 
Cluster unweighted cases weighted cases 
1	 1819.0 1819.0 
2	 1251.0 1251.0 
3	 2938.0 2938.0 
r~isslng 6185
 
Total 6008.0 6008.0
 
•
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* * * * * * * * * * * * * * * * * * * * * * * * * QUI C K C L U 5 T E R * * * * * * * * * * * * * * * * * * * * * * * * * 
InItial Cluster Centers. 
Cluster 11·1PORHl FEV FVC FEVl 
1 
2 
3 
1.0000 
1.0000 
1.0000 
64.1000 
84.9100 
35.3500 
14.3000 
172.6800 
129.6900 
10.0900 
150.4500 
48.5900 
- - - - - - - ­ - - ­ - - - - - - ­ - - - ­ - - - - ­ - ­ - - - ­ -
Classification Cluster Centers. 
Cluster IMPORTM FEV FVC FEVl 
1 
2 
3 
3.7929 
2.5675 
3.4043 
39.8732 
80.5924 
58.6756 
47.3084 
125.4203 
95.5309 
19.9954 
113.1029 
61.9253 
- - ­ - - - - ­ - ­ - - - - - - - - ­ - - - - - - - - - - ­ - - ­ -
Final Cluster Centers. 
Cluster IMPORTM FEV FVC FEVl 
1 3.40l13 45.4341 53.0171 26.8405 
2 2.4158 82.7902 11'3.4465 102.6389 
3 2.9335 68.9998 90.1445 68.8836 
- - - - - - - - - - - ­ - ­ - - - ­ - ­ - - ­ - - ­ - - ­ - - ­ - -
:t>' 
'\:l 
'tj 
I'D 
::s 
0. 
..... 
>< 
(") 
Number of Cases in each Cluster. 
Cluster unwelghted cases weighted cases 
1 
2 
3 
1259.0 
2013.0 
2736.0 
1259.0 
2013.0 
2736.0 
Missing
Tota I 
6185 
6008.0 6008.0 
,
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* * * * * * * * * * * * * * * * * * * * * * * * * QUI C K C L U S T E R * * * * * * * * * * * * * * * * * * * * * * * * * 
Initial Cluster Centers. 
Cluster CODEG FEV FVC FEVl 
1 
2 
3 
4.0000 
4.0000 
4.0000 
84.9100 
64.1000 
35.3500 
172.6800 
14.3000 
129.6900 
150.4500 
10.0900 
48.5900 
- - - - - - - - - - - - -
. 
- - - - - ­ - - - - - - - - - - - - - - -
Classification Cluster Centers. 
Cluster CODEG FEV FVC FEVl 
1 1.9880 60.5924 125.4203 
2 2.4534 39.8732 47.3084 
3 2.4640 58.6756 95.5309 
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Final Cluster Centers. 
Cluster CODEG FEV FVC 
1 1.6930 82.7923 113.4438 
2 2.6029 45.4341 53.0171 
3 2.1535 68.9982 90.1464 
113.1029 
19.9954 
61.9253 
- - - ­ --
FEVl 
102.6395 
26.8405 
68.8832 
):0 
'0 
'0 
III 
~ 
C. 
~. 
>: 
o 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Number of Cases in each Cluster. 
Cluster unweighted cases weighted cases 
1 
2 
3 
2013.0 
1259.0 
2736.0 
2013.0 
1259.0 
2736.0 
Missing
Total 
6185 
6008.0 6008.0 
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IMPOHH\ 
Value Label Value Frequency Percent 
Vall d 
Percent 
Cum 
Percent 
1.00 
2.00 
3.00 
5.00 
6.00 
7.00 
8.00 
5035 
313 
11119 
924 
20113 
2154 
305 
------­
41.3 
2.6 
11.6 
7.6 
16.8 
17.7 
2.5 
------­
41.3 
2.6 
11.6 
7.6 
16.8 
17.7 
2.5 
------­
41.3 
113.9 
55.5 
63.1 
79.8 
97.5 
100.0 
Tots I 12193 100.0 100.0 
I
-------------------------------+ 
1.00 I 5035 I
-------------------------------+ 
I 
--+ 
2.00 I I 313 
--+ 
I 
---------+3.00 I 1419 I 
---------+ 
I 
------+ 
5.00 I 924 I 
------+ 
I 
-------------+6.00 I 2043 I 
-------------+ 
-------------+7.00 I 2154 I 
-------------+ 
I 
--+ 
8.00 I I 305 
--+ 
I 
1••••••••• 1••••••••• 1••••••••• 1••••••••• 1••••••••• 1 
o 1600 3200 4800 6400 8000 
Frequency 
Valid cases 12193 Hissing cases o 
Page 
):II 
'\J 
'0 (!) 
:s 
c. 
.... 
:< 
~ 
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- - - - - - - - - - - - - -
PEA R SON COR R E L A T ION C 0 E F F I C lEN T S - - - - - - - - - - - - - ­
IMPORTM CODES STRAIN CODEG FEV FVC FEVl 
I~lPORTM 1.0000 
(12193) 
P= . 
.0473 
(12193) 
P= .000 
.3779 
(10997) 
P= .000 
.2091 
(12193) 
P= .000 
-.1880 
( 6008) 
P= .000 
-.1277 
( 6008) 
P= .000 
-.1661 
( 6008) 
P= .000 
CODES .0473 
(12193) 
p= .000 
1. 0000 
(12193) 
P= . 
-.1564 
(10997) 
P= .000 
-.6264 
(12193) 
P= .000 
.2864 
( 6008) 
P= .000 
.2150 
( 6008) 
P= .000 
.2656 
( 6008) 
P= .000 
STRAIN 
CODEG 
.. 3779 
( 10997) 
p= .000 
.2091 
(12193) 
P= .000 
-.1564 
(10997) 
P= .000 
-.6264 
(12193) 
P= .000 
1.0000 
(10997) 
p= .
. 
.2545 
( 10997) 
P= .000 
.2545 
(10997) 
P= .000 
1. 0000 
(12193) 
p= . 
-.1830 
( 4812) 
p= .000 
-.2853 
( 6008) 
p= .000 
-.1074 
( 4812) 
P= .000 
-.1984 
( 6008) 
p= .000 
-.1492 
( 4812) 
P= .000 
-.2562 
( 6008) 
P= .000 
FEV 
FVC 
-.1880 
( 6008) 
p= .000 
-.1277 
( 6008) 
p= .000 
. 2864 
( 6008) 
p= .000 
.2150 
( 6008) 
p= .000 
-.1830 
( 4812) 
p= .000 
-.1074 
( 4812) 
p= .000 
-.2853 
( 6008) 
p= .000 
-.1984 
( 6008) 
p= .000 
1. 0000 
( 6008) 
p= . 
.5927 
( 6008) 
p= .000 
.5927 
( 6008) 
p= .000 
1.0000 
( 6008) 
p= . 
.8528 
( 6008) 
P= .000 
.9071 
( 6008) 
P= .000 
> 
'0 
'0 
CD 
::s 
0­
.... 
FEVl -.1661 
( 6008) 
p= .000 
.2656 
( 6008) 
p= .000 
-.1492 
( 4812) 
p= .000 
-.2562 
( 6008) 
p= .000 
.8528 
( 6008) 
p= .000 
.9071 
( 6008) 
P= .000 
1.0000 
( 6008) 
P= 
>< 
~ 
(COEFFiCiENT / (CASES) / 1-TAILED SIG) " • « IS PRINTED IF A COEFFICIENT CANNOT BE COMPUTED 
